Feedback PLC Launch of CareLocker to enhance Bleepa technology (1876L)
09 September 2021 - 8:00AM
UK Regulatory
TIDMFDBK
RNS Number : 1876L
Feedback PLC
09 September 2021
Prior to publication, the information contained within this
announcement was deemed by the Company to constitute inside
information as stipulated under the Market Abuse Regulations (EU)
No. 596/2014 ("MAR"). With the publication of this announcement,
this information is now considered to be in the public domain.
Feedback plc
Feedback announces launch of CareLocker to enhance its Bleepa
technology
-- Revolutionary GDPR compliant patient-centric cloud
architecture to underly the Bleepa platform
-- Increases the opportunities for Bleepa adoption across multiple care settings
-- Proprietary technology enables an easy route to creation and
mobilisation of individual healthcare records
-- The perfect infrastructure to support roll-out of regional
care delivery programmes such as the Community Diagnostic Hub
initiative
London, 09 September 2021 : Feedback plc (AIM: FDBK, "Feedback"
or the "Company"), the specialist clinical communication company,
announces that it is launching a new Bleepa product -
CareLocker.
CareLocker is a new proprietary and patient-centric cloud
architecture that supports Bleepa's functionality whilst
simultaneously creating patient specific records of care episodes.
CareLocker will enable Bleepa to deliver care across provider
settings in a secure and scalable way.
Bleepa provides practitioners with mobile access to patient
data, including medical images, allowing secure communication and
on-the-go decision making. As a clinical tool Bleepa integrates
with multiple hospital systems and centralises relevant clinical
data around specific patient episodes, from which clinical teams
can accelerate decision making capabilities through the platform.
This data includes lab results, structured reports, ECGs and most
importantly medical images, which are uniquely displayed through
Bleepa's regulated DICOM viewer. CareLocker provides a
patient-centric way of storing data and because the patient record
is de-centralised, they can be accessed by any care setting through
open Application Programming Interfaces (APIs) such as FHIR.
CareLocker provides patient-centric cloud data stores:
containers that store medical data at an individual patient level.
With this proprietary architecture, patient data can be secured at
the individual level, with access control even to subsets of a
patient's data. CareLocker offers opportunities for improved
storage optimisation making it more cost effective than traditional
data storage architectures. Most importantly, CareLockers can be
built on a patient-by-patient basis, allowing organisations to
transition to a cloud architecture as patients enter care pathways
rather than having to undertake the mass data migrations usually
associated with cloud transitions.
Where Bleepa is installed in multiple regional provider
settings, the migration of data into a patient specific record can
happen at a regional level, breaking down provider siloes. One
topical area of application is in facilitating the GBP10bn
Community Diagnostic Hub (CDH) initiative launched by NHS England
to help address the elective care backlog by bringing diagnostic
services out of hospital settings and closer to patients. [1] CDHs
will typically complete a suite of diagnostic tests, the results of
which must all be made available to the clinical teams, both in the
primary and secondary care setting, creating a patient pathway that
bridges multiple care settings. This end-to-end patient-specific
pathway requires a digital infrastructure designed to both connect
clinical teams and manage the associated data flow. Bleepa and
CareLocker in combination provide this, with Bleepa as an
application and user interface and CareLocker as the underlying
data architecture.
Dr Tom Oakley, CEO of Feedback, said: "CareLocker is the latest
development in the Bleepa story and has the potential to be a
significant catalyst to multiple commercial opportunities. We have
been working on this concept for many months in order to position
Bleepa for multi-site adoption and to meet the emerging needs of
the CDH initiative to address the elective care backlog. Currently
patient data is siloed within disparate hospital systems and within
individual clinical settings, this makes delivering regional care
extremely difficult. In some cases it can take hours to transfer
imaging between two hospitals and this ultimately effects patient
care. CareLocker is a solution that can transform care delivery at
an individual hospital, regional or even national level.
Patient-centric cloud storage is the future of medical data and a
natural result of patient centred care. We believe Carelocker
provides the platform our customers need and is right at the
cutting edge of communication technology. With this platform in
place we will be accelerating the opportunities for adoption across
multiple settings."
Further information on CareLocker can be found on the Company's
website www.fbkmed.com
-Ends-
Enquiries:
Feedback plc +44 (0)1954 718072
Tom Oakley, CEO IR@fbk.com
Lindsay Melvin, CFO
Panmure Gordon (UK) Limited (NOMAD
and Broker)
Emma Earl/Freddy Crossley (Corporate
Finance)
Rupert Dearden (Corporate Broking) +44 (0)20 7886 2500
Walbrook PR Ltd Tel: 020 7933 8780 or feedbackplc@walbrookpr.com
Paul McManus/Nick Rome/Nicholas 07980 541 893 or 07748 325 236
Johnson or 07884 664 686
Notes to Editors
Feedback plc (AIM: FDBK) is a pioneer of regulated clinical
communication products. Its core product, Bleepa, is a
revolutionary medical imaging communications app, providing an
easy-to-use, high quality tool to enable remote and secure
communications between front-line clinicians and teams.
Importantly, it is the only CE marked medical imaging
communications platform on the NHSx clinical communications tools
framework. Bleepa has unparalleled functionality for everyday
practice and can be accessed from any internet-connected device,
enabling control of patient cases when on the go.
Its highly scalable Software as a Service ("SaaS") based revenue
model will provide increasing levels of visibility as the Company
grows its customer base. With a growing distribution base and
technology in place, the focus is on leveraging key relationships
in order to drive sales both in the UK and internationally to all
forms of care providers. As a fully certified medical device,
Bleepa aims to disrupt the medical imaging communications market
and, importantly, increase the accuracy and speed of clinical
review.
[1]
https://uk.eu-supply.com/ctm/Supplier/PublicTenders/ViewNotice/26333
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
PRLUWUWRASUKRAR
(END) Dow Jones Newswires
September 09, 2021 02:00 ET (06:00 GMT)
Feedback (LSE:FDBK)
Historical Stock Chart
Von Jun 2024 bis Jul 2024
Feedback (LSE:FDBK)
Historical Stock Chart
Von Jul 2023 bis Jul 2024